India's widening water deficit could create an infrastructure investment opportunity worth over Rs 20 lakh crore over the next decade, acco...

India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...

Mercury Retrograde 2026 in Cancer beginning June 29, 2026 intensifies emotional memory loops, pulling unresolved relationships back into fo...

Cancer Weekly Horoscope (29th June 2026 to 5th July 2026): Your Weekly Horoscope brings a week of important interactions. The Moon starts t...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Cancer Weekly Horoscope (27th June 2026 to 3rd July 2026): Cancer, this week places you at the center of a powerful personal transformation...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...

Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...

The writer recalls how her mother used to take a self-declared three-day "vacation" during menstruation, avoiding household work and spendi...

The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

A groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...

India's health sector has seen historic changes in the last 12 years. Accessible, affordable, and quality healthcare is now a reality for c...